Global Recombinant DNA Technology Market Research Report 2025(Status and Outlook)

March 2025 | 185 pages | ID: GBBC826A57B8EN
Bosson Research

Abstracts

Report Overview

Recombinant DNA technology involves the manipulation of DNA to create new combinations of genetic material. This process allows scientists to insert specific genes from one organism into another, leading to the production of desired proteins or traits. Recombinant DNA technology plays a crucial role in various fields such as medicine, agriculture, and biotechnology. In medicine, it is used to produce therapeutic proteins like insulin and growth hormones. In agriculture, it helps in developing genetically modified crops with improved traits such as pest resistance and higher yields. The biotechnology industry extensively utilizes recombinant DNA technology for research, drug development, and the production of biofuels.

The market for recombinant DNA technology is witnessing significant growth driven by several factors. The increasing demand for biopharmaceuticals and genetically modified crops is fueling the adoption of recombinant DNA technology. The ability of this technology to produce complex proteins and enhance crop characteristics is driving its application in various industries. Moreover, advancements in gene editing techniques like CRISPR-Cas9 are expanding the possibilities of recombinant DNA technology, further boosting market growth. Additionally, the rising prevalence of genetic disorders and the need for personalized medicine are creating opportunities for the expansion of this market. Overall, the market for recombinant DNA technology is poised for continuous growth and innovation in the coming years.

This report provides a deep insight into the global Recombinant DNA Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Recombinant DNA Technology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Recombinant DNA Technology market in any manner.

Global Recombinant DNA Technology Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Monsanto Company

Roche

Biogen

Amgen

Novartis

Eli Lilly and Company

GenScript

Pfizer Inc.

Novo Nordisk

Sanofi

Merck KGaA

Profacgen

Biocon

GlaxoSmithKline

Cibus

Horizon Discovery Group

New England Biolabs

Market Segmentation (by Type)

Therapeutic Agent

Vaccine

Biotech Crops

Specialty Chemicals

Market Segmentation (by Application)

Biotechnology and Pharmaceutical Companies

Academic & Government Research Institutes

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Recombinant DNA Technology Market
• Overview of the regional outlook of the Recombinant DNA Technology Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Recombinant DNA Technology Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Recombinant DNA Technology
1.2 Key Market Segments
1.2.1 Recombinant DNA Technology Segment by Type
1.2.2 Recombinant DNA Technology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Recombinant DNA Technology Market Overview
2.1 Global Market Overview
2.1.1 Global Recombinant DNA Technology Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Recombinant DNA Technology Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Recombinant DNA Technology Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Recombinant DNA Technology Product Life Cycle
3.3 Global Recombinant DNA Technology Sales by Manufacturers (2020-2025)
3.4 Global Recombinant DNA Technology Revenue Market Share by Manufacturers (2020-2025)
3.5 Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Recombinant DNA Technology Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Recombinant DNA Technology Manufacturing Sites, Area Served, Product Type
3.8 Recombinant DNA Technology Market Competitive Situation and Trends
3.8.1 Recombinant DNA Technology Market Concentration Rate
3.8.2 Global 5 and 10 Largest Recombinant DNA Technology Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Recombinant DNA Technology Industry Chain Analysis
4.1 Recombinant DNA Technology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Recombinant DNA Technology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Recombinant DNA Technology Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Recombinant DNA Technology Market
5.7 ESG Ratings of Leading Companies
6 Recombinant DNA Technology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Recombinant DNA Technology Sales Market Share by Type (2020-2025)
6.3 Global Recombinant DNA Technology Market Size Market Share by Type (2020-2025)
6.4 Global Recombinant DNA Technology Price by Type (2020-2025)
7 Recombinant DNA Technology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Recombinant DNA Technology Market Sales by Application (2020-2025)
7.3 Global Recombinant DNA Technology Market Size (M USD) by Application (2020-2025)
7.4 Global Recombinant DNA Technology Sales Growth Rate by Application (2020-2025)
8 Recombinant DNA Technology Market Sales by Region
8.1 Global Recombinant DNA Technology Sales by Region
8.1.1 Global Recombinant DNA Technology Sales by Region
8.1.2 Global Recombinant DNA Technology Sales Market Share by Region
8.2 Global Recombinant DNA Technology Market Size by Region
8.2.1 Global Recombinant DNA Technology Market Size by Region
8.2.2 Global Recombinant DNA Technology Market Size Market Share by Region
8.3 North America
8.3.1 North America Recombinant DNA Technology Sales by Country
8.3.2 North America Recombinant DNA Technology Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Recombinant DNA Technology Sales by Country
8.4.2 Europe Recombinant DNA Technology Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Recombinant DNA Technology Sales by Region
8.5.2 Asia Pacific Recombinant DNA Technology Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Recombinant DNA Technology Sales by Country
8.6.2 South America Recombinant DNA Technology Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Recombinant DNA Technology Sales by Region
8.7.2 Middle East and Africa Recombinant DNA Technology Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Recombinant DNA Technology Market Production by Region
9.1 Global Production of Recombinant DNA Technology by Region(2020-2025)
9.2 Global Recombinant DNA Technology Revenue Market Share by Region (2020-2025)
9.3 Global Recombinant DNA Technology Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Recombinant DNA Technology Production
9.4.1 North America Recombinant DNA Technology Production Growth Rate (2020-2025)
9.4.2 North America Recombinant DNA Technology Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Recombinant DNA Technology Production
9.5.1 Europe Recombinant DNA Technology Production Growth Rate (2020-2025)
9.5.2 Europe Recombinant DNA Technology Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Recombinant DNA Technology Production (2020-2025)
9.6.1 Japan Recombinant DNA Technology Production Growth Rate (2020-2025)
9.6.2 Japan Recombinant DNA Technology Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Recombinant DNA Technology Production (2020-2025)
9.7.1 China Recombinant DNA Technology Production Growth Rate (2020-2025)
9.7.2 China Recombinant DNA Technology Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Monsanto Company
10.1.1 Monsanto Company Basic Information
10.1.2 Monsanto Company Recombinant DNA Technology Product Overview
10.1.3 Monsanto Company Recombinant DNA Technology Product Market Performance
10.1.4 Monsanto Company Business Overview
10.1.5 Monsanto Company SWOT Analysis
10.1.6 Monsanto Company Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Recombinant DNA Technology Product Overview
10.2.3 Roche Recombinant DNA Technology Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Biogen
10.3.1 Biogen Basic Information
10.3.2 Biogen Recombinant DNA Technology Product Overview
10.3.3 Biogen Recombinant DNA Technology Product Market Performance
10.3.4 Biogen Business Overview
10.3.5 Biogen SWOT Analysis
10.3.6 Biogen Recent Developments
10.4 Amgen
10.4.1 Amgen Basic Information
10.4.2 Amgen Recombinant DNA Technology Product Overview
10.4.3 Amgen Recombinant DNA Technology Product Market Performance
10.4.4 Amgen Business Overview
10.4.5 Amgen Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis Recombinant DNA Technology Product Overview
10.5.3 Novartis Recombinant DNA Technology Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Eli Lilly and Company
10.6.1 Eli Lilly and Company Basic Information
10.6.2 Eli Lilly and Company Recombinant DNA Technology Product Overview
10.6.3 Eli Lilly and Company Recombinant DNA Technology Product Market Performance
10.6.4 Eli Lilly and Company Business Overview
10.6.5 Eli Lilly and Company Recent Developments
10.7 GenScript
10.7.1 GenScript Basic Information
10.7.2 GenScript Recombinant DNA Technology Product Overview
10.7.3 GenScript Recombinant DNA Technology Product Market Performance
10.7.4 GenScript Business Overview
10.7.5 GenScript Recent Developments
10.8 Pfizer Inc.
10.8.1 Pfizer Inc. Basic Information
10.8.2 Pfizer Inc. Recombinant DNA Technology Product Overview
10.8.3 Pfizer Inc. Recombinant DNA Technology Product Market Performance
10.8.4 Pfizer Inc. Business Overview
10.8.5 Pfizer Inc. Recent Developments
10.9 Novo Nordisk
10.9.1 Novo Nordisk Basic Information
10.9.2 Novo Nordisk Recombinant DNA Technology Product Overview
10.9.3 Novo Nordisk Recombinant DNA Technology Product Market Performance
10.9.4 Novo Nordisk Business Overview
10.9.5 Novo Nordisk Recent Developments
10.10 Sanofi
10.10.1 Sanofi Basic Information
10.10.2 Sanofi Recombinant DNA Technology Product Overview
10.10.3 Sanofi Recombinant DNA Technology Product Market Performance
10.10.4 Sanofi Business Overview
10.10.5 Sanofi Recent Developments
10.11 Merck KGaA
10.11.1 Merck KGaA Basic Information
10.11.2 Merck KGaA Recombinant DNA Technology Product Overview
10.11.3 Merck KGaA Recombinant DNA Technology Product Market Performance
10.11.4 Merck KGaA Business Overview
10.11.5 Merck KGaA Recent Developments
10.12 Profacgen
10.12.1 Profacgen Basic Information
10.12.2 Profacgen Recombinant DNA Technology Product Overview
10.12.3 Profacgen Recombinant DNA Technology Product Market Performance
10.12.4 Profacgen Business Overview
10.12.5 Profacgen Recent Developments
10.13 Biocon
10.13.1 Biocon Basic Information
10.13.2 Biocon Recombinant DNA Technology Product Overview
10.13.3 Biocon Recombinant DNA Technology Product Market Performance
10.13.4 Biocon Business Overview
10.13.5 Biocon Recent Developments
10.14 GlaxoSmithKline
10.14.1 GlaxoSmithKline Basic Information
10.14.2 GlaxoSmithKline Recombinant DNA Technology Product Overview
10.14.3 GlaxoSmithKline Recombinant DNA Technology Product Market Performance
10.14.4 GlaxoSmithKline Business Overview
10.14.5 GlaxoSmithKline Recent Developments
10.15 Cibus
10.15.1 Cibus Basic Information
10.15.2 Cibus Recombinant DNA Technology Product Overview
10.15.3 Cibus Recombinant DNA Technology Product Market Performance
10.15.4 Cibus Business Overview
10.15.5 Cibus Recent Developments
10.16 Horizon Discovery Group
10.16.1 Horizon Discovery Group Basic Information
10.16.2 Horizon Discovery Group Recombinant DNA Technology Product Overview
10.16.3 Horizon Discovery Group Recombinant DNA Technology Product Market Performance
10.16.4 Horizon Discovery Group Business Overview
10.16.5 Horizon Discovery Group Recent Developments
10.17 New England Biolabs
10.17.1 New England Biolabs Basic Information
10.17.2 New England Biolabs Recombinant DNA Technology Product Overview
10.17.3 New England Biolabs Recombinant DNA Technology Product Market Performance
10.17.4 New England Biolabs Business Overview
10.17.5 New England Biolabs Recent Developments
11 Recombinant DNA Technology Market Forecast by Region
11.1 Global Recombinant DNA Technology Market Size Forecast
11.2 Global Recombinant DNA Technology Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Recombinant DNA Technology Market Size Forecast by Country
11.2.3 Asia Pacific Recombinant DNA Technology Market Size Forecast by Region
11.2.4 South America Recombinant DNA Technology Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Recombinant DNA Technology by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Recombinant DNA Technology Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Recombinant DNA Technology by Type (2026-2033)
12.1.2 Global Recombinant DNA Technology Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Recombinant DNA Technology by Type (2026-2033)
12.2 Global Recombinant DNA Technology Market Forecast by Application (2026-2033)
12.2.1 Global Recombinant DNA Technology Sales (K Units) Forecast by Application
12.2.2 Global Recombinant DNA Technology Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Recombinant DNA Technology Market Size Comparison by Region (M USD)
Table 5. Global Recombinant DNA Technology Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Recombinant DNA Technology Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Recombinant DNA Technology Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Recombinant DNA Technology Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2024)
Table 10. Global Market Recombinant DNA Technology Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Recombinant DNA Technology Manufacturing Sites and Area Served
Table 12. Manufacturers Recombinant DNA Technology Product Type
Table 13. Global Recombinant DNA Technology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Recombinant DNA Technology Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Recombinant DNA Technology Sales by Type (K Units)
Table 25. Global Recombinant DNA Technology Market Size by Type (M USD)
Table 26. Global Recombinant DNA Technology Sales (K Units) by Type (2020-2025)
Table 27. Global Recombinant DNA Technology Sales Market Share by Type (2020-2025)
Table 28. Global Recombinant DNA Technology Market Size (M USD) by Type (2020-2025)
Table 29. Global Recombinant DNA Technology Market Size Share by Type (2020-2025)
Table 30. Global Recombinant DNA Technology Price (USD/Unit) by Type (2020-2025)
Table 31. Global Recombinant DNA Technology Sales (K Units) by Application
Table 32. Global Recombinant DNA Technology Market Size by Application
Table 33. Global Recombinant DNA Technology Sales by Application (2020-2025) & (K Units)
Table 34. Global Recombinant DNA Technology Sales Market Share by Application (2020-2025)
Table 35. Global Recombinant DNA Technology Market Size by Application (2020-2025) & (M USD)
Table 36. Global Recombinant DNA Technology Market Share by Application (2020-2025)
Table 37. Global Recombinant DNA Technology Sales Growth Rate by Application (2020-2025)
Table 38. Global Recombinant DNA Technology Sales by Region (2020-2025) & (K Units)
Table 39. Global Recombinant DNA Technology Sales Market Share by Region (2020-2025)
Table 40. Global Recombinant DNA Technology Market Size by Region (2020-2025) & (M USD)
Table 41. Global Recombinant DNA Technology Market Size Market Share by Region (2020-2025)
Table 42. North America Recombinant DNA Technology Sales by Country (2020-2025) & (K Units)
Table 43. North America Recombinant DNA Technology Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Recombinant DNA Technology Sales by Country (2020-2025) & (K Units)
Table 45. Europe Recombinant DNA Technology Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Recombinant DNA Technology Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Recombinant DNA Technology Market Size by Region (2020-2025) & (M USD)
Table 48. South America Recombinant DNA Technology Sales by Country (2020-2025) & (K Units)
Table 49. South America Recombinant DNA Technology Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Recombinant DNA Technology Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Recombinant DNA Technology Market Size by Region (2020-2025) & (M USD)
Table 52. Global Recombinant DNA Technology Production (K Units) by Region(2020-2025)
Table 53. Global Recombinant DNA Technology Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Recombinant DNA Technology Revenue Market Share by Region (2020-2025)
Table 55. Global Recombinant DNA Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Recombinant DNA Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Recombinant DNA Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Recombinant DNA Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Recombinant DNA Technology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Monsanto Company Basic Information
Table 61. Monsanto Company Recombinant DNA Technology Product Overview
Table 62. Monsanto Company Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Monsanto Company Business Overview
Table 64. Monsanto Company SWOT Analysis
Table 65. Monsanto Company Recent Developments
Table 66. Roche Basic Information
Table 67. Roche Recombinant DNA Technology Product Overview
Table 68. Roche Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Roche Business Overview
Table 70. Roche SWOT Analysis
Table 71. Roche Recent Developments
Table 72. Biogen Basic Information
Table 73. Biogen Recombinant DNA Technology Product Overview
Table 74. Biogen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Biogen Business Overview
Table 76. Biogen SWOT Analysis
Table 77. Biogen Recent Developments
Table 78. Amgen Basic Information
Table 79. Amgen Recombinant DNA Technology Product Overview
Table 80. Amgen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Amgen Business Overview
Table 82. Amgen Recent Developments
Table 83. Novartis Basic Information
Table 84. Novartis Recombinant DNA Technology Product Overview
Table 85. Novartis Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Novartis Business Overview
Table 87. Novartis Recent Developments
Table 88. Eli Lilly and Company Basic Information
Table 89. Eli Lilly and Company Recombinant DNA Technology Product Overview
Table 90. Eli Lilly and Company Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Eli Lilly and Company Business Overview
Table 92. Eli Lilly and Company Recent Developments
Table 93. GenScript Basic Information
Table 94. GenScript Recombinant DNA Technology Product Overview
Table 95. GenScript Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. GenScript Business Overview
Table 97. GenScript Recent Developments
Table 98. Pfizer Inc. Basic Information
Table 99. Pfizer Inc. Recombinant DNA Technology Product Overview
Table 100. Pfizer Inc. Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Pfizer Inc. Business Overview
Table 102. Pfizer Inc. Recent Developments
Table 103. Novo Nordisk Basic Information
Table 104. Novo Nordisk Recombinant DNA Technology Product Overview
Table 105. Novo Nordisk Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Novo Nordisk Business Overview
Table 107. Novo Nordisk Recent Developments
Table 108. Sanofi Basic Information
Table 109. Sanofi Recombinant DNA Technology Product Overview
Table 110. Sanofi Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Sanofi Business Overview
Table 112. Sanofi Recent Developments
Table 113. Merck KGaA Basic Information
Table 114. Merck KGaA Recombinant DNA Technology Product Overview
Table 115. Merck KGaA Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Merck KGaA Business Overview
Table 117. Merck KGaA Recent Developments
Table 118. Profacgen Basic Information
Table 119. Profacgen Recombinant DNA Technology Product Overview
Table 120. Profacgen Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Profacgen Business Overview
Table 122. Profacgen Recent Developments
Table 123. Biocon Basic Information
Table 124. Biocon Recombinant DNA Technology Product Overview
Table 125. Biocon Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Biocon Business Overview
Table 127. Biocon Recent Developments
Table 128. GlaxoSmithKline Basic Information
Table 129. GlaxoSmithKline Recombinant DNA Technology Product Overview
Table 130. GlaxoSmithKline Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. GlaxoSmithKline Business Overview
Table 132. GlaxoSmithKline Recent Developments
Table 133. Cibus Basic Information
Table 134. Cibus Recombinant DNA Technology Product Overview
Table 135. Cibus Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Cibus Business Overview
Table 137. Cibus Recent Developments
Table 138. Horizon Discovery Group Basic Information
Table 139. Horizon Discovery Group Recombinant DNA Technology Product Overview
Table 140. Horizon Discovery Group Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Horizon Discovery Group Business Overview
Table 142. Horizon Discovery Group Recent Developments
Table 143. New England Biolabs Basic Information
Table 144. New England Biolabs Recombinant DNA Technology Product Overview
Table 145. New England Biolabs Recombinant DNA Technology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. New England Biolabs Business Overview
Table 147. New England Biolabs Recent Developments
Table 148. Global Recombinant DNA Technology Sales Forecast by Region (2026-2033) & (K Units)
Table 149. Global Recombinant DNA Technology Market Size Forecast by Region (2026-2033) & (M USD)
Table 150. North America Recombinant DNA Technology Sales Forecast by Country (2026-2033) & (K Units)
Table 151. North America Recombinant DNA Technology Market Size Forecast by Country (2026-2033) & (M USD)
Table 152. Europe Recombinant DNA Technology Sales Forecast by Country (2026-2033) & (K Units)
Table 153. Europe Recombinant DNA Technology Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Asia Pacific Recombinant DNA Technology Sales Forecast by Region (2026-2033) & (K Units)
Table 155. Asia Pacific Recombinant DNA Technology Market Size Forecast by Region (2026-2033) & (M USD)
Table 156. South America Recombinant DNA Technology Sales Forecast by Country (2026-2033) & (K Units)
Table 157. South America Recombinant DNA Technology Market Size Forecast by Country (2026-2033) & (M USD)
Table 158. Middle East and Africa Recombinant DNA Technology Sales Forecast by Country (2026-2033) & (Units)
Table 159. Middle East and Africa Recombinant DNA Technology Market Size Forecast by Country (2026-2033) & (M USD)
Table 160. Global Recombinant DNA Technology Sales Forecast by Type (2026-2033) & (K Units)
Table 161. Global Recombinant DNA Technology Market Size Forecast by Type (2026-2033) & (M USD)
Table 162. Global Recombinant DNA Technology Price Forecast by Type (2026-2033) & (USD/Unit)
Table 163. Global Recombinant DNA Technology Sales (K Units) Forecast by Application (2026-2033)
Table 164. Global Recombinant DNA Technology Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Recombinant DNA Technology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Recombinant DNA Technology Market Size (M USD), 2024-2033
Figure 5. Global Recombinant DNA Technology Market Size (M USD) (2020-2033)
Figure 6. Global Recombinant DNA Technology Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Recombinant DNA Technology Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Recombinant DNA Technology Product Life Cycle
Figure 13. Recombinant DNA Technology Sales Share by Manufacturers in 2024
Figure 14. Global Recombinant DNA Technology Revenue Share by Manufacturers in 2024
Figure 15. Recombinant DNA Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Recombinant DNA Technology Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Recombinant DNA Technology Revenue in 2024
Figure 18. Industry Chain Map of Recombinant DNA Technology
Figure 19. Global Recombinant DNA Technology Market PEST Analysis
Figure 20. Global Recombinant DNA Technology Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Recombinant DNA Technology Market Share by Type
Figure 27. Sales Market Share of Recombinant DNA Technology by Type (2020-2025)
Figure 28. Sales Market Share of Recombinant DNA Technology by Type in 2024
Figure 29. Market Size Share of Recombinant DNA Technology by Type (2020-2025)
Figure 30. Market Size Share of Recombinant DNA Technology by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Recombinant DNA Technology Market Share by Application
Figure 33. Global Recombinant DNA Technology Sales Market Share by Application (2020-2025)
Figure 34. Global Recombinant DNA Technology Sales Market Share by Application in 2024
Figure 35. Global Recombinant DNA Technology Market Share by Application (2020-2025)
Figure 36. Global Recombinant DNA Technology Market Share by Application in 2024
Figure 37. Global Recombinant DNA Technology Sales Growth Rate by Application (2020-2025)
Figure 38. Global Recombinant DNA Technology Sales Market Share by Region (2020-2025)
Figure 39. Global Recombinant DNA Technology Market Size Market Share by Region (2020-2025)
Figure 40. North America Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Recombinant DNA Technology Sales Market Share by Country in 2024
Figure 43. North America Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Recombinant DNA Technology Market Size Market Share by Country in 2024
Figure 45. U.S. Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Recombinant DNA Technology Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Recombinant DNA Technology Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Recombinant DNA Technology Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Recombinant DNA Technology Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Recombinant DNA Technology Sales Market Share by Country in 2024
Figure 53. Europe Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Recombinant DNA Technology Market Size Market Share by Country in 2024
Figure 55. Germany Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Recombinant DNA Technology Sales Market Share by Region in 2024
Figure 67. Asia Pacific Recombinant DNA Technology Market Size Market Share by Region in 2024
Figure 68. China Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 79. South America Recombinant DNA Technology Sales Market Share by Country in 2024
Figure 80. South America Recombinant DNA Technology Market Size and Growth Rate (M USD)
Figure 81. South America Recombinant DNA Technology Market Size Market Share by Country in 2024
Figure 82. Brazil Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Recombinant DNA Technology Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Recombinant DNA Technology Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Recombinant DNA Technology Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Recombinant DNA Technology Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Recombinant DNA Technology Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Recombinant DNA Technology Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Recombinant DNA Technology Production Market Share by Region (2020-2025)
Figure 103. North America Recombinant DNA Technology Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Recombinant DNA Technology Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Recombinant DNA Technology Production (K Units) Growth Rate (2020-2025)
Figure 106. China Recombinant DNA Technology Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Recombinant DNA Technology Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Recombinant DNA Technology Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Recombinant DNA Technology Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Recombinant DNA Technology Market Share Forecast by Type (2026-2033)
Figure 111. Global Recombinant DNA Technology Sales Forecast by Application (2026-2033)
Figure 112. Global Recombinant DNA Technology Market Share Forecast by Application (2026-2033)